[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].

doi:10.3760/cma.j.issn.1001-0939.2020.02.009

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases - 12 Feb 2020

Cao H, Zheng J, Zhao J, Guo X J, Zhou J Y, Ding W, Zhou J Y

Abstract excerpt

Objective: To study the prevalence of c-ros oncogene 1 fusion in lung adenocarcinoma and to evaluate its relationship with clinical characteristics. Methods: We retrospectively analyzed epidermal growth factor receptor (EGFR) mutation, anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1)...

Topics

Adenocarcinoma of Lung
Adult
Aged
Anaplastic Lymphoma Kinase
China
ErbB Receptors
Female
Gene Fusion
Genes, erbB-1
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Oncogene Proteins, Fusion
Prevalence
Protein-Tyrosine Kinases
Proto-Oncogene Proteins

Source

Open in PubMed

Identifiers

PMID: 32062881
DOI: 10.3760/cma.j.issn.1001-0939.2020.02.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-32062881-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics